AbbVie (ABBV) Pension (2012 - 2015)

AbbVie (ABBV) reported Pension of $1.9 billion for Q4 2015, down 12.21% year-over-year from $2.2 billion in Q4 2014, and down 12.21% quarter-over-quarter from $2.2 billion in Q4 2014.

AbbVie (ABBV) Pension (2012 - 2015) Analysis & Trends

AbbVie (ABBV) has 4 years of Pension data on file, last reported at $1.9 billion in Q4 2015.

  • Pension for Q4 2015 came in at $1.9 billion, down 12.21% year-over-year; the trailing twelve-month figure through Dec 2015 was $1.9 billion (down 12.21% YoY), and the FY2015 annual result was $1.9 billion, down 12.21% from the prior year.
  • Pension declined to $1.9 billion in Q4 2015 per ABBV's latest filing, from $2.2 billion in the prior quarter.
  • Over five years, Pension peaked at $2.2 billion in Q4 2014 and troughed at $979.0 million in Q4 2012.
  • A 4-year average of $1.7 billion and a median of $1.8 billion in 2013 frame the typical range for Pension.
  • The sharpest annual moves came in 2013 and 2015: Pension soared 66.29% in 2013, then slipped 12.21% in 2015.
  • A 4-year view of Pension shows it stood at $979.0 million in 2012, then surged by 66.29% to $1.6 billion in 2013, then surged by 36.36% to $2.2 billion in 2014, then dropped by 12.21% to $1.9 billion in 2015.
  • Business Quant data shows ABBV's Pension at $1.9 billion in Q4 2015, $2.2 billion in Q4 2014, and $1.6 billion in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2015 1.95 Bn
Dec 31, 2014 2.22 Bn
Dec 31, 2013 1.63 Bn
Dec 31, 2012 979.00 Mn